Merck (MRK) Says HPS2-THRIVE Missed Primary Endpoint
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/18/2026
- Wall St ends lower for the day and week as chip selloff broadens
- Netflix earnings forecast disappoints Wall Street, shares tumble
- HSBC upgrades Apple to Buy, sees "strong cycle ahead"
- Kimi K3 AI breakthrough: What Wall Street analysts say about China’s OpenAI threat
- Why the Fed may still need to hike rates
- Assassin's Creed Black Flag Resynced sells 3M copies in a week
- Magnitude 7.4 earthquake strikes coast of Chiapas, Mexico; Tsunami waves are possible
- Magnitude 7.4 earthquake strikes Puerto Madero, Mexico, USGS says
- Adobe has received a takeover approach by a Big Tech company - Betaville
- Medifast launches Trilivy, replacing its Optavia brand
Merck's (MRK) Tredaptive Miss May Benefit Amarin (AMRN) - Analyst
December 20, 2012 2:12 PM ESTAmarin (Nasdaq: AMRN) shares are pressured today, down about 3.8 percent on the session. But, could there be some good news on the horizon for the pharmceutical company?
Jefferies analyst Thomas Wei thinks so. According to Wei, Merck's (NYSE: MRK)... More
